Distribution and Clinicopathologic Characteristics of Spinal Column Lesions (A 10-Year Study)

Document Type : Original Article

Authors

1 Department of Orthopedic Surgery, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

10.22034/ijos.2025.246028
Abstract
Introduction: Spine is a critical component of the musculoskeletal system, and lesions involving vertebrae may significantly affect patients’ quality of life. Benign spinal lesions, such as infections, can be curable but are often difficult to diagnose, whereas malignant lesions—including sarcomas and metastatic tumors—carry a poor prognosis.
Materials & Methods: This descriptive cross-sectional study included 114 patients diagnosed with benign and malignant spinal lesions between 2008 and 2018 in 2 teaching hospital. Data were collected using a structured questionnaire and analyzed using SPSS version 22. Variables included age, sex, pathology type, lesion type (benign/malignant), size, anatomical origin, and year of diagnosis.
Results & Discussion: 114 patients with mean age of 52.1 ± 20.5 years (range: 1 month–89 years) were studied. Males accounted for 80 (70.2%) of cases. Of all the lesions, 63 (55.3%) were benign and 51 (44.7%) malignant. Lumbar involvement was the most location frequent (64%), followed by thoracic (20.2%), sacral (13.2%), and cervical (2.6%). Pathologically, inflammatory lesions were most common (49.1%), followed by cancers (38.6%), lymphomas (4.4%), benign tumors (3.5%), sarcomas (0.9%), and others (3.5%). No significant association was observed between lesion type and sex, age, lesion site, or age at diagnosis (p>0.05).
Conclusion: Benign lesions—particularly inflammatory ones—represented the majority of spinal pathologies, though malignant lesions comprised nearly half of cases. The lumbar region was most commonly affected. These findings underscore the importance of comprehensive diagnostic approaches and points to need for further multicenter studies to improve management of spinal lesions.

Keywords

Subjects

Hans B. Spinal cord tumors. In: Rosai J, editor. Rosai and Ackerman’s Surgical Pathology. 9th ed. St. Louis: Mosby; 2004.
2.     Harrop JS, Sharan AD. Spinal cord tumors: management of intradural intramedullary neoplasms [Internet]. eMedicine; 2007 Jan [cited 2007 Jan]. Available from: http://www.emedicine.com/med/topic2905.html
3.     Huff JS. Neoplasms, spinal cord [Internet]. eMedicine; 2004 Jun. Available from: http://www.emedicine.com/emerg/topic337.html
4.     Bach F, Larsen BH, Rohde K. Metastatic spinal cord compression. Acta Neurochir. 1999;107(1-2):37-43.
5.     Winn HR, editor. Youmans Neurological Surgery. 5th ed. Philadelphia: Saunders; 2003. p. 4817-4834.
6.     Fan Y, Xia Y, Zhao H, Zhang J, Li S, Tian Y, Weng X, Qiu G. Complications analysis of posterior vertebral column resection in 40 patients with spinal tumors. Exp Ther Med. 2014 Nov;8(5):1539-1544. doi: 10.3892/etm.2014.1929. Epub 2014 Aug 22. PMID: 25289056; PMCID: PMC4186366.
7.     Erfani M, Nouraei H, Namazi H. Evaluation of Histopathology of Vertebral Tumors in 20 Years in Medical Centers of Shiraz University; Comparison with Other Reports: https://sid.ir/paper/549489/en
8.     Weinstein JN, McLain RF. Primary tumors of the spine. Spine (Phila Pa 1976). 1987 Nov;12(9):843-51. doi: 10.1097/00007632-198711000-00004. PMID: 3441830.